| Field | Specification |
|---|---|
| Mfr No | |
| Assay Time | |
| Assay Type | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma |
| Species | |
| Target |
Background
hepatitis B virus e antigen (HBeAg) is a biological molecule commonly studied in microbiology research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
Biological context
Researchers often monitor hepatitis B virus e antigen (HBeAg) in serum and plasma to better understand themes such as infection and host defense, pathogen-associated inflammatory responses, and microbial–host interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in hepatitis B virus e antigen (HBeAg) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, host-response mediators, barrier markers, and pathogen-associated immune readouts) and by keeping pre-analytical variables consistent across groups.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that hepatitis B virus e antigen (HBeAg) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Development of a representative 3D human model derived from iPSC to study hepatitis B virus in vitro
N Eugène,Thesis & Dissertation,2025
Hepatitis B Virus X Protein Induces Reactive Oxygen Species Generation via Activation of p53 in Human Hepatoma Cells
S Kim, J Park, J Han, KL Jang,Biomolecules,2024
Inhibition of Pim kinases triggers a broad antiviral activity by affecting innate immunity and via the PI3K-Akt-mTOR axis the endolysosomal system
M Glitscher,Antiviral research,2024
Replication-driven HBV cccDNA loss in chimeric mice with humanized livers
BH Zhang,/,2023
Integrated analysis of multiple transcriptomic data identifies ST8SIA6‑AS1 and LINC01093 as potential biomarkers in HBV‑associated liver cancer
J Xue,Oncology letters,2023
Tumor Suppressor p53 Inhibits Hepatitis B Virus Replication by Downregulating HBx via E6AP-Mediated Proteasomal Degradation in Human Hepatocellular Carcinoma Cell Lines
HY Lim,Viruses,2022
Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA
ES Kim,PLoS pathogens,2022
Production of Recombinant Hepatitis B virus (HBV) and Detection of HBV in Infected Human Liver Organoids
T Hossain,Bio-protocol,2022
Circ-ATP5H Induces Hepatitis B Virus Replication and Expression by Regulating miR-138-5p/TNFAIP3 Axis
W Jiang,Cancer Management and Research,2020
Quadruple mutation GCAC1809-1812TTCT acts as a biomarker in healthy European HBV carriers
KH Peiffer,JCI Insight.,2020